I
IMMUNOPRECISE ANTIBODIES LTD
NASDAQ: IPA (ImmunoPrecise Antibodies Ltd.)
Last update: 8 hours ago1.88
0.33 (21.29%)
| Previous Close | 1.55 |
| Open | 1.57 |
| Volume | 2,242,360 |
| Avg. Volume (3M) | 1,873,473 |
| Market Cap | 95,538,984 |
| Price / Sales | 3.32 |
| Price / Book | 5.98 |
| 52 Weeks Range | |
| Earnings Date | 10 Dec 2025 |
| Profit Margin | -194.79% |
| Operating Margin (TTM) | -53.47% |
| Diluted EPS (TTM) | -1.22 |
| Quarterly Revenue Growth (YOY) | -1.10% |
| Total Debt/Equity (MRQ) | 51.46% |
| Current Ratio (MRQ) | 2.32 |
| Operating Cash Flow (TTM) | -7.91 M |
| Levered Free Cash Flow (TTM) | -3.63 M |
| Return on Assets (TTM) | -14.88% |
| Return on Equity (TTM) | -124.75% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Bullish | Mixed |
| Biotechnology (Global) | Bullish | Mixed | |
| Stock | ImmunoPrecise Antibodies Ltd. | Mixed | Bearish |
AIStockmoo Score
-0.4
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | -4.5 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | 0.0 |
| Average | -0.38 |
|
ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 5.21% |
| % Held by Institutions | 8.65% |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |